PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34771286-0	2021	Fabrication of 3D Printed Poly(lactic acid)/Polycaprolactone Scaffolds Using TGF-beta1 for Promoting Bone Regeneration.	polycaprolactone	44-60	transforming growth factor beta 1	Homo sapiens	77-86	
28132919-5	2017	Here we demonstrate that the modification of films of polycaprolactone (PCL) with transforming growth factor beta1 (TGF-beta1)-binding peptides allows GFs to be captured and presented to the target cells.	polycaprolactone	72-75	transforming growth factor beta 1	Homo sapiens	82-114	
29683273-3	2018	For wound healing, transforming growth factor-beta1 is incorporated into polycaprolactone/collagen (PCL/Coll) nanofibers via electrospinning and the myofibroblastic differentiation of human dermal fibroblasts is locally stimulated.	polycaprolactone	73-89	transforming growth factor beta 1	Homo sapiens	19-51	
28875694-3	2017	Herein, we present a TGF-beta1-inhibitor-doped poly(epsilon-caprolactone) (PCL)/gelatin (PG) coelectrospun nanofibrous scaffold (PGT) for HS prevention during wound healing.	polycaprolactone	47-73	transforming growth factor beta 1	Homo sapiens	21-30	
28875694-3	2017	Herein, we present a TGF-beta1-inhibitor-doped poly(epsilon-caprolactone) (PCL)/gelatin (PG) coelectrospun nanofibrous scaffold (PGT) for HS prevention during wound healing.	polycaprolactone	75-78	transforming growth factor beta 1	Homo sapiens	21-30	
28132919-0	2017	TGF-beta1 activation in human hamstring cells through growth factor binding peptides on polycaprolactone surfaces.	polycaprolactone	88-104	transforming growth factor beta 1	Homo sapiens	0-9	
28132919-5	2017	Here we demonstrate that the modification of films of polycaprolactone (PCL) with transforming growth factor beta1 (TGF-beta1)-binding peptides allows GFs to be captured and presented to the target cells.	polycaprolactone	54-70	transforming growth factor beta 1	Homo sapiens	82-114	
28132919-5	2017	Here we demonstrate that the modification of films of polycaprolactone (PCL) with transforming growth factor beta1 (TGF-beta1)-binding peptides allows GFs to be captured and presented to the target cells.	polycaprolactone	54-70	transforming growth factor beta 1	Homo sapiens	116-125	
28132919-5	2017	Here we demonstrate that the modification of films of polycaprolactone (PCL) with transforming growth factor beta1 (TGF-beta1)-binding peptides allows GFs to be captured and presented to the target cells.	polycaprolactone	72-75	transforming growth factor beta 1	Homo sapiens	116-125	
20827712-4	2011	As the first step, this study sought to determine the optimal dosage of TGF-beta1 on polycaprolactone (PCL) scaffolds cultured with primary human osteoblasts (HOBs) to effectively induce in vitro calcification.	polycaprolactone	85-101	transforming growth factor beta 1	Homo sapiens	72-81	
20827712-4	2011	As the first step, this study sought to determine the optimal dosage of TGF-beta1 on polycaprolactone (PCL) scaffolds cultured with primary human osteoblasts (HOBs) to effectively induce in vitro calcification.	polycaprolactone	103-106	transforming growth factor beta 1	Homo sapiens	72-81	
21115281-5	2011	The initial fast releases of TGF-beta1 from different microspheres could be significantly decreased with increasing polycaprolactone content in CPCs, and some microspheres were able to maintain sustained releases of TGF-beta1 by mainly controlling their composition.	polycaprolactone	116-132	transforming growth factor beta 1	Homo sapiens	29-38